Page last updated: 2024-10-29

ifosfamide and Leukemia, Plasma Cell

ifosfamide has been researched along with Leukemia, Plasma Cell in 1 studies

Leukemia, Plasma Cell: A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.

Research Excerpts

ExcerptRelevanceReference
"We report two patients with primary plasma cell leukemia (PLC) treated with a single agent, ifosfamide."2.38Ifosfamide in plasma cell leukemia: a report of two cases and review of the literature. ( Advani, SH; Dhabhar, BN; Gopal, R; Malhotra, H; Nadkarni, KS; Nair, CN; Saikia, TK, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malhotra, H1
Dhabhar, BN1
Saikia, TK1
Gopal, R1
Nadkarni, KS1
Nair, CN1
Advani, SH1

Reviews

1 review available for ifosfamide and Leukemia, Plasma Cell

ArticleYear
Ifosfamide in plasma cell leukemia: a report of two cases and review of the literature.
    American journal of hematology, 1992, Volume: 40, Issue:3

    Topics: Adult; Female; Humans; Ifosfamide; Leukemia, Plasma Cell; Middle Aged

1992